MedTrace Logo

Autologous Bone Marrow Concentrate in Elective Tranforaminal Lumbar Interbody Fusion Surgery

NCT03793530 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-04-14

No results posted yet for this study

Summary

This study aims to evaluate the effect of bone marrow concentration on bone healing and spinal fusion by comparing clinical and imaging outcomes between patients receiving transforaminal lumbar intebody fusion with local bone graft and with intraoperative bone marrow concentration and those receiving transforaminal lumbar intebody fusion with local bone graft only.

Conditions

  • Bone Marrow
  • Spinal Fusion

Interventions

OTHER

Transforaminal lumbar interbody fusion with local bone graft and intraoperative bone marrow concentration

Transforaminal lumbar interbody fusion with local bone graft and intraoperative bone marrow concentration

OTHER

Transforaminal lumbar interbody fusion with local bone graft

Transforaminal lumbar interbody fusion with local bone graft

Sponsors & Collaborators

  • Aeon Biotechnology Corporation

    collaborator INDUSTRY

  • Pei-Yuan Lee, MD

    lead OTHER

Principal Investigators

  • Pei-Yuan Lee, MD · Show Chwan Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03793530 on ClinicalTrials.gov